Structure

Physi-Chem Properties

Molecular Weight:  566.35
Volume:  581.709
LogP:  2.169
LogD:  1.625
LogS:  -3.826
# Rotatable Bonds:  8
TPSA:  153.75
# H-Bond Aceptor:  9
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.241
Synthetic Accessibility Score:  5.805
Fsp3:  0.871
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.563
MDCK Permeability:  1.8719039871939458e-05
Pgp-inhibitor:  0.229
Pgp-substrate:  0.99
Human Intestinal Absorption (HIA):  0.073
20% Bioavailability (F20%):  0.067
30% Bioavailability (F30%):  0.295

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.246
Plasma Protein Binding (PPB):  44.431983947753906%
Volume Distribution (VD):  0.565
Pgp-substrate:  22.582902908325195%

ADMET: Metabolism

CYP1A2-inhibitor:  0.005
CYP1A2-substrate:  0.85
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.819
CYP2C9-inhibitor:  0.005
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.001
CYP2D6-substrate:  0.033
CYP3A4-inhibitor:  0.896
CYP3A4-substrate:  0.504

ADMET: Excretion

Clearance (CL):  2.499
Half-life (T1/2):  0.495

ADMET: Toxicity

hERG Blockers:  0.221
Human Hepatotoxicity (H-HT):  0.689
Drug-inuced Liver Injury (DILI):  0.024
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.171
Maximum Recommended Daily Dose:  0.888
Skin Sensitization:  0.055
Carcinogencity:  0.888
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.968

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475036

Natural Product ID:  NPC475036
Common Name*:   Methyl (4As,4Bs,6As,7S,8R,9R,10S,10As,10Br,12As)-4A,9,10-Trihydroxy-8-[(1R)-1-Hydroxyethyl]-8-(Hydroxymethyl)-7-(3-Methoxy-3-Oxopropyl)-3,6A,10B,12A-Tetramethyl-1,4,5,6,7,9,10,10A,11,12-Decahydrochrysene-4B-Carboxylate
IUPAC Name:   methyl (4aS,4bS,6aS,7S,8R,9R,10S,10aS,10bR,12aS)-4a,9,10-trihydroxy-8-[(1R)-1-hydroxyethyl]-8-(hydroxymethyl)-7-(3-methoxy-3-oxopropyl)-3,6a,10b,12a-tetramethyl-1,4,5,6,7,9,10,10a,11,12-decahydrochrysene-4b-carboxylate
Synonyms:  
Standard InCHIKey:  RBKYLTMXHKKOOD-ISGLCVLNSA-N
Standard InCHI:  InChI=1S/C31H50O9/c1-18-10-11-26(3)12-14-28(5)23-22(35)24(36)29(17-32,19(2)33)20(8-9-21(34)39-6)27(23,4)13-15-30(28,25(37)40-7)31(26,38)16-18/h10,19-20,22-24,32-33,35-36,38H,8-9,11-17H2,1-7H3/t19-,20+,22+,23+,24+,26-,27+,28-,29-,30+,31+/m1/s1
SMILES:  CC1=CCC2(CCC3(C4C(C(C(C(C4(CCC3(C2(C1)O)C(=O)OC)C)CCC(=O)OC)(CO)C(C)O)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL493644
PubChem CID:   44566235
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0001757] Colensane and clerodane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19117 Galphimia glauca Species Malpighiaceae Eukaryota n.a. n.a. n.a. PMID[12398543]
NPO19117 Galphimia glauca Species Malpighiaceae Eukaryota sedative extracts n.a. n.a. PMID[15104495]
NPO19117 Galphimia glauca Species Malpighiaceae Eukaryota n.a. n.a. n.a. PMID[16441069]
NPO19117 Galphimia glauca Species Malpighiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Activity = 76.8 % PMID[527388]
NPT32 Organism Mus musculus Mus musculus Activity = 61.8 % PMID[527388]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475036 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.899 High Similarity NPC35239
0.8972 High Similarity NPC134430
0.8922 High Similarity NPC477877
0.89 High Similarity NPC256247
0.8889 High Similarity NPC111214
0.8889 High Similarity NPC271614
0.8889 High Similarity NPC29765
0.8878 High Similarity NPC476327
0.8878 High Similarity NPC25848
0.8878 High Similarity NPC476318
0.8878 High Similarity NPC19376
0.8878 High Similarity NPC307282
0.8878 High Similarity NPC305464
0.8878 High Similarity NPC201657
0.8868 High Similarity NPC7921
0.8868 High Similarity NPC208998
0.8857 High Similarity NPC171888
0.8857 High Similarity NPC146945
0.8824 High Similarity NPC284865
0.8807 High Similarity NPC77689
0.8807 High Similarity NPC473636
0.8796 High Similarity NPC475809
0.8788 High Similarity NPC106112
0.8788 High Similarity NPC247139
0.8788 High Similarity NPC255589
0.8788 High Similarity NPC9613
0.8788 High Similarity NPC261935
0.8788 High Similarity NPC43686
0.8788 High Similarity NPC259788
0.8776 High Similarity NPC473240
0.8776 High Similarity NPC32118
0.875 High Similarity NPC293850
0.8725 High Similarity NPC225238
0.8716 High Similarity NPC297179
0.8713 High Similarity NPC476132
0.87 High Similarity NPC260149
0.87 High Similarity NPC58942
0.8687 High Similarity NPC132824
0.8687 High Similarity NPC207922
0.8687 High Similarity NPC259733
0.8687 High Similarity NPC73004
0.8687 High Similarity NPC204961
0.8687 High Similarity NPC173744
0.8687 High Similarity NPC158371
0.8673 High Similarity NPC299996
0.8673 High Similarity NPC88116
0.8673 High Similarity NPC231063
0.8673 High Similarity NPC145667
0.8673 High Similarity NPC32407
0.8673 High Similarity NPC263548
0.8673 High Similarity NPC282395
0.8673 High Similarity NPC20235
0.8636 High Similarity NPC473839
0.8636 High Similarity NPC211093
0.8624 High Similarity NPC470854
0.8624 High Similarity NPC287343
0.8624 High Similarity NPC122033
0.8624 High Similarity NPC470775
0.8624 High Similarity NPC176513
0.8624 High Similarity NPC474654
0.8624 High Similarity NPC97908
0.8614 High Similarity NPC476195
0.8611 High Similarity NPC475633
0.86 High Similarity NPC189880
0.8598 High Similarity NPC277769
0.8598 High Similarity NPC48249
0.8586 High Similarity NPC96916
0.8571 High Similarity NPC133579
0.8571 High Similarity NPC136313
0.8571 High Similarity NPC474806
0.8571 High Similarity NPC307335
0.8571 High Similarity NPC275809
0.8571 High Similarity NPC74855
0.8558 High Similarity NPC80566
0.8545 High Similarity NPC17772
0.8545 High Similarity NPC204552
0.8545 High Similarity NPC251310
0.8545 High Similarity NPC188667
0.8545 High Similarity NPC470776
0.8544 High Similarity NPC90177
0.8532 High Similarity NPC40632
0.8532 High Similarity NPC152199
0.8532 High Similarity NPC474046
0.8532 High Similarity NPC96312
0.8532 High Similarity NPC134869
0.8532 High Similarity NPC251236
0.8532 High Similarity NPC235539
0.8532 High Similarity NPC259306
0.8532 High Similarity NPC474734
0.8532 High Similarity NPC328374
0.8532 High Similarity NPC470628
0.8529 High Similarity NPC54909
0.8529 High Similarity NPC233012
0.8519 High Similarity NPC269315
0.8519 High Similarity NPC475208
0.8519 High Similarity NPC49451
0.8519 High Similarity NPC238935
0.8519 High Similarity NPC271138
0.8515 High Similarity NPC174663
0.8515 High Similarity NPC188833
0.8515 High Similarity NPC475876
0.8505 High Similarity NPC31839
0.85 High Similarity NPC88847
0.8491 Intermediate Similarity NPC218853
0.8491 Intermediate Similarity NPC310546
0.8491 Intermediate Similarity NPC143706
0.8491 Intermediate Similarity NPC472534
0.8485 Intermediate Similarity NPC159365
0.8485 Intermediate Similarity NPC6818
0.8485 Intermediate Similarity NPC470958
0.8485 Intermediate Similarity NPC191412
0.8485 Intermediate Similarity NPC474529
0.8485 Intermediate Similarity NPC470957
0.8485 Intermediate Similarity NPC114159
0.8482 Intermediate Similarity NPC75417
0.8476 Intermediate Similarity NPC59530
0.8469 Intermediate Similarity NPC966
0.8469 Intermediate Similarity NPC288833
0.8469 Intermediate Similarity NPC84319
0.8469 Intermediate Similarity NPC282616
0.8469 Intermediate Similarity NPC71074
0.8469 Intermediate Similarity NPC25299
0.8469 Intermediate Similarity NPC52021
0.8469 Intermediate Similarity NPC300351
0.8469 Intermediate Similarity NPC306541
0.8469 Intermediate Similarity NPC472149
0.8469 Intermediate Similarity NPC235884
0.8469 Intermediate Similarity NPC228784
0.8469 Intermediate Similarity NPC324341
0.8469 Intermediate Similarity NPC155120
0.8462 Intermediate Similarity NPC65523
0.8455 Intermediate Similarity NPC473590
0.844 Intermediate Similarity NPC469877
0.844 Intermediate Similarity NPC470919
0.844 Intermediate Similarity NPC473798
0.844 Intermediate Similarity NPC117712
0.844 Intermediate Similarity NPC474906
0.844 Intermediate Similarity NPC243354
0.844 Intermediate Similarity NPC18547
0.8426 Intermediate Similarity NPC80843
0.8426 Intermediate Similarity NPC46388
0.8426 Intermediate Similarity NPC90952
0.8426 Intermediate Similarity NPC280782
0.8426 Intermediate Similarity NPC116794
0.8426 Intermediate Similarity NPC474516
0.8426 Intermediate Similarity NPC289312
0.8426 Intermediate Similarity NPC11252
0.8426 Intermediate Similarity NPC4573
0.8426 Intermediate Similarity NPC302146
0.8426 Intermediate Similarity NPC37739
0.8426 Intermediate Similarity NPC1046
0.8416 Intermediate Similarity NPC476879
0.8416 Intermediate Similarity NPC187933
0.8416 Intermediate Similarity NPC476878
0.8411 Intermediate Similarity NPC220984
0.8411 Intermediate Similarity NPC7870
0.8411 Intermediate Similarity NPC242611
0.8411 Intermediate Similarity NPC274507
0.8411 Intermediate Similarity NPC102914
0.8411 Intermediate Similarity NPC75747
0.8411 Intermediate Similarity NPC199457
0.8411 Intermediate Similarity NPC68419
0.8411 Intermediate Similarity NPC108709
0.8411 Intermediate Similarity NPC110139
0.84 Intermediate Similarity NPC23241
0.84 Intermediate Similarity NPC266899
0.84 Intermediate Similarity NPC195715
0.84 Intermediate Similarity NPC53565
0.84 Intermediate Similarity NPC474727
0.8396 Intermediate Similarity NPC273155
0.8393 Intermediate Similarity NPC112038
0.8384 Intermediate Similarity NPC158059
0.8384 Intermediate Similarity NPC229281
0.8384 Intermediate Similarity NPC202728
0.8384 Intermediate Similarity NPC118519
0.8381 Intermediate Similarity NPC472655
0.8381 Intermediate Similarity NPC278628
0.8381 Intermediate Similarity NPC102352
0.8381 Intermediate Similarity NPC470587
0.8381 Intermediate Similarity NPC231530
0.8378 Intermediate Similarity NPC286347
0.8367 Intermediate Similarity NPC86372
0.8367 Intermediate Similarity NPC49320
0.8367 Intermediate Similarity NPC172361
0.8367 Intermediate Similarity NPC126369
0.8367 Intermediate Similarity NPC130278
0.8367 Intermediate Similarity NPC470589
0.8367 Intermediate Similarity NPC111110
0.8365 Intermediate Similarity NPC95899
0.8364 Intermediate Similarity NPC207217
0.835 Intermediate Similarity NPC118964
0.8349 Intermediate Similarity NPC477266
0.8349 Intermediate Similarity NPC47063
0.8349 Intermediate Similarity NPC138334
0.8349 Intermediate Similarity NPC194273
0.8349 Intermediate Similarity NPC204458
0.8349 Intermediate Similarity NPC189884
0.8333 Intermediate Similarity NPC30397
0.8333 Intermediate Similarity NPC477875
0.8333 Intermediate Similarity NPC108748

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475036 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8125 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.8017 Intermediate Similarity NPD8328 Phase 3
0.7921 Intermediate Similarity NPD7515 Phase 2
0.7913 Intermediate Similarity NPD6319 Approved
0.789 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7767 Intermediate Similarity NPD7748 Approved
0.7745 Intermediate Similarity NPD6411 Approved
0.7714 Intermediate Similarity NPD7902 Approved
0.7706 Intermediate Similarity NPD6402 Approved
0.7706 Intermediate Similarity NPD5739 Approved
0.7706 Intermediate Similarity NPD7128 Approved
0.7706 Intermediate Similarity NPD6675 Approved
0.7699 Intermediate Similarity NPD4632 Approved
0.7686 Intermediate Similarity NPD7319 Approved
0.7658 Intermediate Similarity NPD6373 Approved
0.7658 Intermediate Similarity NPD6372 Approved
0.7611 Intermediate Similarity NPD8297 Approved
0.7603 Intermediate Similarity NPD7736 Approved
0.7589 Intermediate Similarity NPD4634 Approved
0.7583 Intermediate Similarity NPD7507 Approved
0.7568 Intermediate Similarity NPD7320 Approved
0.7568 Intermediate Similarity NPD6899 Approved
0.7568 Intermediate Similarity NPD6881 Approved
0.7549 Intermediate Similarity NPD5764 Clinical (unspecified phase)
0.7549 Intermediate Similarity NPD6101 Approved
0.7522 Intermediate Similarity NPD6650 Approved
0.7522 Intermediate Similarity NPD6649 Approved
0.75 Intermediate Similarity NPD5779 Approved
0.75 Intermediate Similarity NPD5778 Approved
0.75 Intermediate Similarity NPD7492 Approved
0.75 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6399 Phase 3
0.75 Intermediate Similarity NPD7115 Discovery
0.7477 Intermediate Similarity NPD5701 Approved
0.7477 Intermediate Similarity NPD5697 Approved
0.7477 Intermediate Similarity NPD7638 Approved
0.7458 Intermediate Similarity NPD6059 Approved
0.7458 Intermediate Similarity NPD6054 Approved
0.7456 Intermediate Similarity NPD6882 Approved
0.7438 Intermediate Similarity NPD6616 Approved
0.7434 Intermediate Similarity NPD6883 Approved
0.7434 Intermediate Similarity NPD7290 Approved
0.7434 Intermediate Similarity NPD7102 Approved
0.7429 Intermediate Similarity NPD7900 Approved
0.7429 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD7639 Approved
0.7407 Intermediate Similarity NPD7640 Approved
0.7387 Intermediate Similarity NPD6008 Approved
0.7383 Intermediate Similarity NPD4755 Approved
0.7379 Intermediate Similarity NPD5328 Approved
0.7377 Intermediate Similarity NPD7078 Approved
0.7377 Intermediate Similarity NPD8293 Discontinued
0.7368 Intermediate Similarity NPD6847 Approved
0.7368 Intermediate Similarity NPD8130 Phase 1
0.7368 Intermediate Similarity NPD6617 Approved
0.7368 Intermediate Similarity NPD6869 Approved
0.735 Intermediate Similarity NPD6009 Approved
0.7345 Intermediate Similarity NPD6014 Approved
0.7345 Intermediate Similarity NPD6013 Approved
0.7345 Intermediate Similarity NPD6012 Approved
0.7333 Intermediate Similarity NPD6370 Approved
0.7327 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6412 Phase 2
0.7281 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7257 Intermediate Similarity NPD6686 Approved
0.7257 Intermediate Similarity NPD6011 Approved
0.725 Intermediate Similarity NPD6015 Approved
0.725 Intermediate Similarity NPD6016 Approved
0.725 Intermediate Similarity NPD8517 Approved
0.725 Intermediate Similarity NPD8515 Approved
0.725 Intermediate Similarity NPD8516 Approved
0.725 Intermediate Similarity NPD8513 Phase 3
0.725 Intermediate Similarity NPD6921 Approved
0.7248 Intermediate Similarity NPD5285 Approved
0.7248 Intermediate Similarity NPD5286 Approved
0.7248 Intermediate Similarity NPD4700 Approved
0.7248 Intermediate Similarity NPD4696 Approved
0.7245 Intermediate Similarity NPD7645 Phase 2
0.7241 Intermediate Similarity NPD8133 Approved
0.7238 Intermediate Similarity NPD6079 Approved
0.7238 Intermediate Similarity NPD8035 Phase 2
0.7238 Intermediate Similarity NPD8034 Phase 2
0.7238 Intermediate Similarity NPD7983 Approved
0.7228 Intermediate Similarity NPD4786 Approved
0.7217 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD3667 Approved
0.719 Intermediate Similarity NPD5988 Approved
0.7184 Intermediate Similarity NPD3573 Approved
0.7156 Intermediate Similarity NPD4225 Approved
0.7131 Intermediate Similarity NPD7604 Phase 2
0.7117 Intermediate Similarity NPD5225 Approved
0.7117 Intermediate Similarity NPD4633 Approved
0.7117 Intermediate Similarity NPD5224 Approved
0.7117 Intermediate Similarity NPD5211 Phase 2
0.7117 Intermediate Similarity NPD5226 Approved
0.7107 Intermediate Similarity NPD5983 Phase 2
0.7087 Intermediate Similarity NPD3618 Phase 1
0.7083 Intermediate Similarity NPD7516 Approved
0.708 Intermediate Similarity NPD4768 Approved
0.708 Intermediate Similarity NPD4767 Approved
0.7064 Intermediate Similarity NPD6083 Phase 2
0.7064 Intermediate Similarity NPD6084 Phase 2
0.7054 Intermediate Similarity NPD5174 Approved
0.7054 Intermediate Similarity NPD5175 Approved
0.7027 Intermediate Similarity NPD5223 Approved
0.7018 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD6336 Discontinued
0.7009 Intermediate Similarity NPD4202 Approved
0.7 Intermediate Similarity NPD7328 Approved
0.7 Intermediate Similarity NPD7525 Registered
0.7 Intermediate Similarity NPD7327 Approved
0.6991 Remote Similarity NPD5141 Approved
0.6975 Remote Similarity NPD6274 Approved
0.6972 Remote Similarity NPD5222 Approved
0.6972 Remote Similarity NPD5221 Approved
0.6972 Remote Similarity NPD4697 Phase 3
0.6972 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6967 Remote Similarity NPD8033 Approved
0.6957 Remote Similarity NPD4729 Approved
0.6957 Remote Similarity NPD4730 Approved
0.6952 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6942 Remote Similarity NPD7100 Approved
0.6942 Remote Similarity NPD7101 Approved
0.6909 Remote Similarity NPD5173 Approved
0.6905 Remote Similarity NPD6033 Approved
0.6903 Remote Similarity NPD4754 Approved
0.6887 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6885 Remote Similarity NPD8377 Approved
0.6885 Remote Similarity NPD8294 Approved
0.6864 Remote Similarity NPD6053 Discontinued
0.686 Remote Similarity NPD6335 Approved
0.6838 Remote Similarity NPD5250 Approved
0.6838 Remote Similarity NPD5249 Phase 3
0.6838 Remote Similarity NPD5247 Approved
0.6838 Remote Similarity NPD5251 Approved
0.6838 Remote Similarity NPD5248 Approved
0.6829 Remote Similarity NPD8335 Approved
0.6829 Remote Similarity NPD8296 Approved
0.6829 Remote Similarity NPD8380 Approved
0.6829 Remote Similarity NPD6909 Approved
0.6829 Remote Similarity NPD8378 Approved
0.6829 Remote Similarity NPD8379 Approved
0.6829 Remote Similarity NPD6908 Approved
0.6825 Remote Similarity NPD8074 Phase 3
0.6822 Remote Similarity NPD46 Approved
0.6822 Remote Similarity NPD6698 Approved
0.6814 Remote Similarity NPD7632 Discontinued
0.681 Remote Similarity NPD5128 Approved
0.68 Remote Similarity NPD6114 Approved
0.68 Remote Similarity NPD6115 Approved
0.68 Remote Similarity NPD6118 Approved
0.68 Remote Similarity NPD6697 Approved
0.6777 Remote Similarity NPD6317 Approved
0.6762 Remote Similarity NPD6684 Approved
0.6762 Remote Similarity NPD7334 Approved
0.6762 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6762 Remote Similarity NPD7146 Approved
0.6762 Remote Similarity NPD6409 Approved
0.6762 Remote Similarity NPD5330 Approved
0.6762 Remote Similarity NPD7521 Approved
0.6759 Remote Similarity NPD7637 Suspended
0.6731 Remote Similarity NPD3668 Phase 3
0.6731 Remote Similarity NPD3665 Phase 1
0.6731 Remote Similarity NPD3666 Approved
0.6731 Remote Similarity NPD3133 Approved
0.6729 Remote Similarity NPD4753 Phase 2
0.6727 Remote Similarity NPD5695 Phase 3
0.6726 Remote Similarity NPD5344 Discontinued
0.6721 Remote Similarity NPD6313 Approved
0.6721 Remote Similarity NPD6314 Approved
0.67 Remote Similarity NPD6116 Phase 1
0.6696 Remote Similarity NPD5696 Approved
0.6694 Remote Similarity NPD7503 Approved
0.6694 Remote Similarity NPD6868 Approved
0.6639 Remote Similarity NPD5216 Approved
0.6639 Remote Similarity NPD5217 Approved
0.6639 Remote Similarity NPD5215 Approved
0.6636 Remote Similarity NPD5737 Approved
0.6636 Remote Similarity NPD6903 Approved
0.6636 Remote Similarity NPD6672 Approved
0.66 Remote Similarity NPD6117 Approved
0.6577 Remote Similarity NPD6356 Clinical (unspecified phase)
0.656 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6555 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6555 Remote Similarity NPD5135 Approved
0.6555 Remote Similarity NPD6371 Approved
0.6555 Remote Similarity NPD5169 Approved
0.6542 Remote Similarity NPD7524 Approved
0.6518 Remote Similarity NPD7839 Suspended
0.6518 Remote Similarity NPD7614 Phase 1
0.6505 Remote Similarity NPD4695 Discontinued
0.65 Remote Similarity NPD6942 Approved
0.65 Remote Similarity NPD3703 Phase 2
0.65 Remote Similarity NPD8413 Clinical (unspecified phase)
0.65 Remote Similarity NPD5127 Approved
0.65 Remote Similarity NPD7339 Approved
0.6486 Remote Similarity NPD5282 Discontinued
0.6457 Remote Similarity NPD6067 Discontinued
0.6455 Remote Similarity NPD5281 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data